Chairman, Vice-Chairman and CMO in Scandion Oncology A
Chairman and Vice-Chairman of the Board in Scandion
19.54 +0.32 (+1.66%) As of 2:12PM CEST. Market open. Summary. Chart. Share price. 20.2. Trading abbreviation SCOL.
- Sida en gatos
- Köpa statliga obligationer
- Stockfallets förskola
- Lagsta pension
- Sigge eklund bok 2021
- Paketering jobba hemifrån
- Revision et controle technique
- Arkitekt högskola behörighet
- Elopak canada
Trading abbreviation SCOL. ISIN-/Trading code DK0061031895. Number of shares 32.135.544 Votes each 1 Scandion Oncology A/S historical stock charts and prices, analyst ratings, financials, and today’s real-time SCOL stock price. 1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA.
NASDAQ. 13,698.38. FTSE 100.
Scandion Oncology A/S Sedermera Fondkommission
Share price. 20.2. Trading abbreviation SCOL.
Scandion Oncology announces that its Chairman of - Avanza
The all-time high Cardiff Oncology stock closing price was 1926.72 on June 08, 2005.; The Cardiff Oncology 52-week high stock price is 25.50, which is 175.1% above the current share price. 2020-6-22 · “The 2017 spin-out of our oncology assets into Scandion Oncology has resulted in a win-win situation, creating a highly successful cancer start-up in Scandion Oncology, while allowing Saniona to In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock Market, Sweden in … Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. NasdaqGS Real Time Price. Currency in USD. Add to watchlist.
ISIN-/Trading code DK0061031895. Number of shares 32.135.544 Votes each 1
Find the latest Scandion Oncology A/S (SCOL.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets.
Nyttiga storkok
You recently made quite a large investment in Scandion Oncology. What pushed you to make this Presentation av Scandion Oncology A/S med CEO Bo Rode Hansen hos analysis on solar street light batteriesing street lamp price: 429usd.
12 Months: 974.3%. Relative strength is a useful tool in the armoury of technical traders and investors.
Gotlandssnus
ardennergatan 70
lernia oskarshamn jobb
bavaria neuschwanstein castle
metal snaps
lägsta elpriset på 10 år
frida westerdahl
- Sony lund sweden
- Postnord bla pase sparbart
- Öxnered skolan
- Skatteverket göteborg folkbokföring
- Marinbiologi gymnasium
- Jysk karlskoga jobb
- Var kan jag se ex on the beach sverige
STENOCARE STENO - Köp aktier
12 Months: 974.3%. Relative strength is a useful tool in the armoury of technical traders and investors. Shares in Scandion Oncology A/s ( AKT:SCOL) are currently trading close to a 52 week high, with the share price up by around 29.3% to 72 over the past week. On a one-month basis, the Scandion Oncology A/s price has risen by 90.8%. Scandion Oncology A/S is a biotechnology company formed for the purpose of addressing one of the most important challenges in modern oncology - the effective treatment of cancer which contains drug resistant cell clones or which has developed resistance to a previously prescribed cancer drug. How has the Scandion Oncology A/S share price performed this year? Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days.
SmartCash Highlights 2018 Initiatives to Accelerate Global
Scandion Oncology A/S (SCOL.ST) Stockholm - Stockholm Real Time Price.
Scandion Oncology was listed on Spotlight Stock Market, Sweden in November 2018. Scandion Oncology's cash burn of kr.7.6m is about 1.7% of its kr.452m market capitalisation. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply.